Chuikyo OKs Listing of Omvoh, Entyvio SC, Besremi, and More; Biggest Sales Outlook for Lilly Drug

Eli Lilly’s ulcerative colitis med Omvoh (mirikizumab) will newly join Japan’s NHI price list along with a throng of other drugs on May 24. Its subcutaneous version carries the largest peak sales forecast among all products on the listing roster...read more